|
|
Volumn 123, Issue 10, 2001, Pages 557-561
|
|
A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer;Palliative therapie bei metastasiertem mammakarzinom mit tamoxifen und hochdosiertem octreotid (somatostatin-analog) - Ergebnisse einer multizentrischen phase-III-studie
a
|
|
Author keywords
Breast cancer; Octreotid; Palliative care
|
|
Indexed keywords
ESTROGEN RECEPTOR;
OCTREOTIDE;
PLACEBO;
PROGESTERONE RECEPTOR;
SOMATOMEDIN C RECEPTOR;
SOMATOSTATIN RECEPTOR;
TAMOXIFEN;
ABDOMINAL PAIN;
ADULT;
AGED;
ARTICLE;
BONE PAIN;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOUBLE BLIND PROCEDURE;
DRUG INDUCED DISEASE;
FATIGUE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
METASTASIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASMS, HORMONE-DEPENDENT;
OCTREOTIDE;
PALLIATIVE CARE;
SURVIVAL RATE;
TAMOXIFEN;
|
|
EID: 0035199903
PISSN: 00444197
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2001-19088 Document Type: Article |
|
Times cited : (3)
|
|
References (16)
|
